ALPHE Share Price Performance
€0
0.00 (0.00%)
Price €0
Share Pricen/a
Pherecydes Pharma Société anonyme Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
ALPHE Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Pherecydes Pharma Société anonyme Key Details
Last Reported Earnings
Dec 31, 2022
Next Reporting Earnings
Sep 19, 2023
- -0.67
- -71.91%
- -153.85%
- 33.7%
About ALPHE
- Founded
- 2006
- Employees
- 29
- CEO
- WebsiteView website
Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-staphylococcus aureus for the treatment of bone/joint and diabetic foot ulcer infections; anti-pseudomonas aeruginosa, a phage therapy treatment for respiratory tract infections; and anti-escherichia coli for the treatment of respiratory tract infections. The company was founded in 2006 and is headquartered in Romainville, France. As of June 21, 2023, Pherecydes Pharma Société anonyme operates as a subsidiary of ERYTECH Pharma S.A..
